$4.12
+0.07 (+1.73%)
Open$4.06
Previous Close$4.05
Day High$4.22
Day Low$4.05
52W High$9.10
52W Low$3.88
Volume—
Avg Volume12.5K
Market Cap46.54M
P/E Ratio—
EPS$-5.34
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+191.7% upside
Current
$4.12
$4.12
Target
$12.02
$12.02
$8.98
$12.02 avg
$15.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.85M | 4.99M | 44.29M |
| Net Income | -105,171,295 | -254,857,742 | 4.55M |
| Profit Margin | -5,668.6% | -5,385.2% | 10.3% |
| EBITDA | -111,439,641 | -285,050,239 | 9.89M |
| Free Cash Flow | — | — | 3.33M |
| Rev Growth | -62.9% | -62.9% | -0.9% |
| Debt/Equity | — | — | 0.50 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |